//
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study